| RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may … C Roche-Lestienne, L Deluche, S Corm, I Tigaud, S Joha, N Philippe, ... Blood, The Journal of the American Society of Hematology 111 (7), 3735-3741, 2008 | 82 | 2008 |
| Exploiting mitochondrial dysfunction for effective elimination of imatinib-resistant leukemic cells J Kluza, M Jendoubi, C Ballot, A Dammak, A Jonneaux, T Idziorek, S Joha, ... PLoS One 6 (7), e21924, 2011 | 66 | 2011 |
| Activity of elaeochytrin A from Ferula elaeochytris on leukemia cell lines R Alkhatib, T Hennebelle, S Joha, T Idziorek, C Preudhomme, B Quesnel, ... Phytochemistry 69 (17), 2979-2983, 2008 | 59 | 2008 |
| BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism J Liu, S Joha, T Idziorek, S Corm, D Hetuin, N Philippe, C Preudhomme, ... Leukemia 22 (4), 791-799, 2008 | 59 | 2008 |
| GILZ inhibits the mTORC2/AKT pathway in BCR-ABL+ cells S Joha, AL Nugues, D Hetuin, C Berthon, X Dezitter, V Dauphin, ... Oncogene 31 (11), 1419-1430, 2012 | 51 | 2012 |
| Activity of ladanein on leukemia cell lines and its occurrence in Marrubium vulgare R Alkhatib, S Joha, M Cheok, V Roumy, T Idziorek, C Preudhomme, ... Planta medica 76 (01), 86-87, 2010 | 50 | 2010 |
| Antifungal and Cytotoxic Activity of Withanolides from Acnistus arborescens V Roumy, M Biabiany, T Hennebelle, EM Aliouat, M Pottier, H Joseph, ... Journal of natural products 73 (7), 1313-1317, 2010 | 30 | 2010 |
| Genomic characterization of Imatinib resistance in CD34+ cell populations from chronic myeloid leukaemia patients S Joha, V Dauphin, F Leprêtre, S Corm, FE Nicolini, C Roumier, ... Leukemia research 35 (4), 448-458, 2011 | 21 | 2011 |
| Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1–PRDM16 fusion in a case of progressive chronic myeloid leukemia … L Deluche, S Joha, S Corm, A Daudignon, S Geffroy, S Quief, C Villenet, ... Genes, Chromosomes and Cancer 47 (12), 1110-1117, 2008 | 21 | 2008 |
| Humulane and Germacrane Sesquiterpenes from Ferula lycia R Alkhatib, T Hennebelle, S Joha, V Roumy, Y Guzel, M Biabiany, ... Journal of natural products 73 (4), 780-783, 2010 | 13 | 2010 |
| Kynurenine-modified serum proteins are a new marker of cardiovascular discorders developing in type 2 diabetes MA Ahmadou, MS JOHA Int J Acad Sci Res 3, 101-5, 2015 | 6 | 2015 |
| Mécanismes de résistance aux inhibiteurs de tyrosine kinase sur le modèle de leucémie myéloïde chronique SM Joha Université du Droit et de la Santé-Lille II, 2009 | 5 | 2009 |
| Evaluation of Fructosamine and Ischemia–Modified Albumin as prognostic markers for cardiovascular disorders in type 2 diabetic patients J Al KRITA, MS JOHA, A IBRAHEEM International Journal of Academic Scientific Research 3 (2), 52-56, 2015 | 1 | 2015 |
| Impact of ABO/Rhesus (D, C, c, E, e) blood type on development of vascular complications in type 2 diabetes B Shalhawi, MS Joha Research Journal of Pharmacy and Technology 16 (9), 4119-4122, 2023 | | 2023 |
| An intronic polymorphism of the gene Plakophilin-3 is associated with IVF failure MA Mohamad Sami Joha, Chadi Soukkarieh International Journal of Reproduction, Contraception, Obstetrics and …, 2019 | | 2019 |
| INFLUENCE OF OBESITY ON ISCHEMIA-MODIFIED ALBUMIN (IMA) AND FRUCTOSAMINE LEVELS MS Joha, A Jehan IJCBS 2 (11), 1-3, 2016 | | 2016 |
| AML1/RUNX1 is frequently altered in chronic myelogenous leukemia in blast crisis and is associated with trisomy 21 C Roche-Lestienne, L Deluche, S Joha, JL Laï, S Corm, FE Nicolini, ... Hématologie 14 (3), 173-176, 2008 | | 2008 |
| New sesquiterpene esters and a saponin from Ferula elaeochytris and their cytotoxic evaluation against leukemia cell lines R Al Khatib, T Hennebelle, S Joha, T Idziorek, C Preudhomme, B Quesnel, ... Planta Medica 74 (09), PB14, 2008 | | 2008 |
| AML1/RUNX1 est souvent altéré dans la leucémie myéloïde chronique en crise blastique et est associé à la trisomie 21 C Roche-Lestienne, L Deluche, S Joha, JL Laï, S Corm, FE Nicolini, ... Hématologie 14 (3), 173-176, 2008 | | 2008 |
| RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusion in BCR/ABL plus leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution … C Roche-Lestienne, L Deluche, S Corm, I Tigaud, S Joha, N Philippe, ... BLOOD 110 (11), 820A-820A, 2007 | | 2007 |
